我省生态环境监测网络实现环境要素全覆盖 每日甘肃网兰州讯（新甘肃·甘肃日报记者顾丽娟）记者从省生态环境厅日前召开的新闻发布会上获 悉，"十四五"期间，甘肃按照"陆河统筹、天地一体、上下协同、信息共享"总体要求，全力构建覆盖 水、气、土、声、生态等要素的监测网络，实现环境要素全覆盖，让全省生态环境变化"看得见、测得 出"。 生态质量监测方面，结合我省生态类型与地理空间分布，布设659个国控生态质量监测样地，实现县级 行政单元全覆盖，涵盖森林、草地、湿地等七大生态系统；建成祁连山国家公园生态环境监测站，加快 推进陇南大熊猫国家公园监测站建设；联合中国科学院西北院、兰州大学等单位，推动8个站点纳入国 家级生态质量综合监测站，形成"监测样地+综合站"的地面监测网络，同时加强重点区域人为活动遥感 监测，有力支撑生态保护监管。 责任编辑：王辉文 水环境监测方面，甘肃布设74个国控、67个省控地表水环境监测断面，覆盖全省3大流域、9个水系；建 成27个国控、14个省控水质自动监测站及12个水质自动预警站，全力保障重要流域与跨界水体安全；常 态化开展142个县级以上集中式饮用水水源地水质监测，并对59个国控点位开展水生态监测 ...

Core Viewpoint - The Hainan Provincial Drug Vigilance Center is enhancing collaboration and utilizing digital tools to improve risk monitoring and ensure medication safety for the public [1][2][3] Group 1: Risk Monitoring and Response - The center identified multiple adverse events related to a specific batch of disposable surgical gloves, indicating potential quality issues [2] - The center's primary responsibility includes monitoring and evaluating adverse reactions and events to mitigate potential safety risks [2][3] - Hainan's drug adverse reaction report total is slightly above the national average, while the center's staff is only one-third of the national average for provincial monitoring agencies, indicating a high workload [3] Group 2: Collaborative Efforts and Training - The center collaborates with the Provincial Health Commission to establish a coordinated assessment mechanism, integrating monitoring into the accountability system for medical institutions [4] - The number of monitoring points has been expanded, and specialized training for monitoring personnel is ongoing to enhance sensitivity in detecting risks [4] Group 3: Digital Tools and Innovations - The center is integrating risk signal identification and rapid reporting of adverse drug reactions into the Hainan "Three Medical Linkage One Network" platform [4][5] - This platform aims to eliminate data silos among departments, making risk monitoring more intelligent and convenient [5] Group 4: Unique Responsibilities and Advantages - Hainan's drug vigilance center has unique tasks due to special policies allowing early use of innovative medical devices not yet registered in China [5][6] - The center has established a comprehensive monitoring system for innovative medical devices used in the Boao Lecheng area, focusing on patient registration, clinical follow-up, and lifecycle traceability [6][7] - The center aims to leverage its policy advantages to enhance research capabilities and improve the drug vigilance system and risk management [7]